One year of treatment with dapirolizumab pegol can reduce fatigue and ease disease activity in people with systemic lupus…
Articles by Andrea Lobo, PhD
The U.S. Food and Drug Administration (FDA) has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Caribou Biosciences‘ CAR T-cell therapy CB-010…
Patient screening is underway in a U.S.-based clinical trial of NKX019, an investigational natural killer (NK) cell therapy for people…
Mutations in the UNC93B1 gene — which produces a protein involved in the regulation of certain immune proteins, called toll-like…
Three women with the autoimmune conditions systemic lupus erythematosus (SLE) and Sjögren’s syndrome saw their symptoms ease after starting a…
Immpact Bio has received an $8 million grant from the California Institute for Regenerative Medicine (CIRM) for its…
The U.S. Food and Drug Administration (FDA) has granted fast track status to AlloNK, an experimental natural killer (NK)…
Atara Biotherapeutics has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for…
A combination of Lupkinis (viclosporin) with mycophenolate mofetil (MMF) was the most effective at managing lupus nephritis, according…